Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paloma Cejas

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Molecular Cell|May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.
Nature Communications|October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancerPaloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
A multi-omics resource of B cell activation reveals genetic mechanisms for immune-mediated diseasesVitor R C Aguiar, Marcella E Franco, Nada Abdel Aziz, et al.
Nature Genetics|May 11, 2021
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependenceZhong Wu, Jin Zhou, Xiaoyang Zhang, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Cancer Cell|January 15, 2020
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic PathwayKari J Kurppa, Yao Liu, Ciric To, et al.
Nature Genetics|July 22, 2020
Prostate cancer reactivates developmental epigenomic programs during metastatic progressionMark M Pomerantz, Xintao Qiu, Yanyun Zhu, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Cell|March 1, 2025
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapyQinqin Jiang, David A Braun, Karl R Clauser, et al.
Cancer Research|July 8, 2022
FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional CircuitsJessica W Tsai, Paloma Cejas, Dayle K Wang, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Molecular Cell|May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.
Nature Communications|October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancerPaloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
A multi-omics resource of B cell activation reveals genetic mechanisms for immune-mediated diseasesVitor R C Aguiar, Marcella E Franco, Nada Abdel Aziz, et al.
Nature Genetics|May 11, 2021
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependenceZhong Wu, Jin Zhou, Xiaoyang Zhang, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Cancer Cell|January 15, 2020
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic PathwayKari J Kurppa, Yao Liu, Ciric To, et al.
Nature Genetics|July 22, 2020
Prostate cancer reactivates developmental epigenomic programs during metastatic progressionMark M Pomerantz, Xintao Qiu, Yanyun Zhu, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Cell|March 1, 2025
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapyQinqin Jiang, David A Braun, Karl R Clauser, et al.
Cancer Research|July 8, 2022
FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional CircuitsJessica W Tsai, Paloma Cejas, Dayle K Wang, et al.
Pageof 9